Latest Leadership And Governance News

Energy Action Limited reported positive operating cash flow for Q2 FY26 and secured a deferral on key loan repayments while investing in its AI-powered platform and appointing new board members.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.

Volt Group Limited has completed its acquisition of 4D Delta and secured a $4 million share placement, marking a significant step in its strategic growth.

Critical Resources has engaged SLR Consulting to streamline permitting for its Mavis Lake Lithium Project in Ontario, aiming to fast-track approvals and secure government funding. This move strengthens the project’s role in North America’s lithium supply chain amid growing demand for sustainable battery materials.

Ardiden Ltd has completed its merger with Lac Gold, combining two premier Canadian gold projects and raising $10 million to fund upcoming drilling programs. The merger creates a stronger, cash-rich entity poised for growth in Quebec and Ontario.

Hancock & Gore reports a statutory loss for FY25 amid major acquisitions and strategic transformation, setting sights on $200m revenue by FY27 as it rebrands to Schoolblazer Limited.

Saunders International reported a challenging FY2025 with profit declines amid operational headwinds but strengthened its Water sector presence through the Aqua Metro acquisition. The company projects a stronger FY2026 backed by a record $4 billion pipeline and improved margins.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

National Australia Bank reported a 1.2% revenue increase to $20.872 billion in FY25, while net profit dipped 2.9% to $6.759 billion. The bank highlighted progress in customer-centric strategy, technology modernization, and sustainability initiatives.

Icetana Limited reports a strategic pivot to a SaaS-driven revenue model with recurring income now dominating its sales, despite a 49% drop in total revenue for FY25. A landmark partnership with SoftBank Robotics aims to fuel growth in Japan and beyond.